The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged <= 65 years

Boegemann Martin; Stephan Carsten; Cammann Henning; Vincendeau Sebastien; Houlgatte Alain; Jung Klaus; Blanchet Jean-Sebastien; Semjonow Axel

首页> 外文期刊>BJU international >The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged <= 65 years

【24h】

The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged <= 65 years

机译：前列腺特异性抗原（PSA）同工型[-2] proPSA的百分比和前列腺健康指数与65岁以下男性的总PSA和游离PSA相比，提高了初次和重复活检时临床相关前列腺癌的诊断准确性。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives

机译：目标

著录项

来源
《BJU international》 |2016年第1期|共8页
作者
Boegemann Martin; Stephan Carsten; Cammann Henning; Vincendeau Sebastien; Houlgatte Alain; Jung Klaus; Blanchet Jean-Sebastien; Semjonow Axel;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
PSA-isoforms; -2proPSA; p2PSA; PHI; over diagnosis; significant prostate cancer;

机译：PSA异构体;[-2] proPSA;p2PSA;PHI;过度诊断;严重前列腺癌;

相似文献

外文文献
中文文献
专利

1. The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged <= 65 years [J] . Boegemann Martin, Stephan Carsten, Cammann Henning, BJU international . 2016,第1期

机译：前列腺特异性抗原（PSA）同工型[-2] proPSA的百分比和前列腺健康指数与65岁以下男性的总PSA和游离PSA相比，提高了初次和重复活检时临床相关前列腺癌的诊断准确性。
2. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting. [J] . Guazzoni G, Nava L, Lazzeri M, European urology . 2011,第2期

机译：前列腺特异性抗原（PSA）同工型p2PSA可显着改善总PSA在2.0到10 ng / ml之间的患者在最初的扩展前列腺活检中对前列腺癌的预测：一项在临床环境中的前瞻性研究结果。
3. Low Percentage of Free Prostate-specific Antigen (PSA) Is a Strong Predictor of Later Detection of Prostate Cancer Among Japanese Men With Serum Levels of Total PSA of 4.0 ng/mL or Less EDITORIAL COMMENT [J] . Loeb Stacy Urology . 2014,第5期

机译：血清总PSA含量为4.0 ng / mL或更低的日本男性中游离前列腺特异性抗原（PSA）的低百分比是后期检测前列腺癌的有力预测指标
4. Qualitative and quantitative investigation of glycans attached to Prostate-specific antigen (PSA) glycoprotein of healthy and cancer samples [C] . Ulrike Schweiger-Hufnagel, Kristina Marx, Wolfgang Jabs, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：对前列腺特异性抗原（PSA）糖蛋白对健康和癌症样品的定性和定量研究
5. Editorial comment to The value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria and Reply by authors [O] . Ahmed Elabbady, Ekene V. Ezenwa 2012

机译：社论评论在尼日利亚总PSA水平中等（4.0–10.0 ng / mL）的患者中前列腺特异性抗原百分比（PSA）在检测前列腺癌中的价值和作者的回复
6. A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men [O] . Nigel P. Murray, Eduardo Reyes, Nelson Orellana, 2014

机译：总PSA的比较性能分析，百分比，PSA，PSA速度和PSA密度对智利男性初始前列腺活检调查中的初级循环前列腺细胞的检测
7. Development of a Novel Methodology for Improving CTL Recognition of Prostate Specific Antigen (PSA) for the Immunotherapy of Prostate Cancer. [R] . Frelinger, J. G. 2003

机译：开发新的方法提高前列腺特异性抗原（psa）的CTL识别前列腺癌的免疫治疗。

The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged <= 65 years

摘要

著录项

相似文献

相关主题

期刊订阅